Trial intelligence / Profile preview

Sirolimus for HIV Reservoir Reduction

NCT02440789Phase 2Completed

Start
Dec 2015
Primary completion
Nov 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sirolimus in human immunodeficiency virus type 1 infection (HIV-1). Started Dec 2015; status: completed.

02

Drugs

sirolimus
03

Conditions

human immunodeficiency virus type 1 infection (HIV-1)

Beyond the preview

Go deeper on NCT02440789.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02440789.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call